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INTRODUCTION
Obesity is a  critical public health issue globally as its overall 
prevalence continues to rise (1). Malta, a  small Mediterranean 
island with a population of less than half a million (2), leads the 
overweight and obesity rankings in Europe (3). A recent study 
that measured the body mass index (BMI) of almost all school-
aged children in Malta reported that around 41% are overweight 
or obese according to WHO cut-offs, with a greater proportion 
being obese (26%) than overweight (15%) (4). Obesity is also 
a  problem in Maltese adults: according to a  recent nationally 
representative study, 36% are overweight and 34% are obese (5). 
The same authors reported a type II diabetes mellitus prevalence 
of 10.4% among the Maltese adult population.
These figures are a particular concern for policy-makers in Malta 
because obesity is a  major risk factor for noncommunicable 
diseases (NCDs) including coronary heart disease (CHD), 
diabetes, hypertension, stroke and certain cancers, and there is 
a  well-established link between obesity, poor health outcomes 
and all-cause mortality (6). Given that health services in Malta 
are mainly provided by the state and free at the point of use 
(albeit with a  substantial private sector acting as a  parallel, 
complementary system for health care coverage and service 
delivery), the direct and indirect economic implications of 
overweight and obesity are significant (7). Health expenditure 
has increased steadily in recent years, exceeding the rise in gross 
domestic product (GDP) (8). The cost of obesity in Malta for 2016 
was conservatively estimated to be around €36.3 million, or 5.6% 
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ABSTRACT
Background: Globally, there is increasing concern about the potential health 
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Research: By 2035, uncontrolled overweight and obesity are projected to 
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coronary heart disease developing as a consequence of obesity is expected to 
double within the next two decades. Associated cumulative direct health care 
costs will amount to around €814  million by 2035. However, a  5% reduction 
in the average population body mass index by 2035 is projected to result in 
a saving of €141 million in health expenditure on obesity-related conditions over 
the intervening 20 years.
Conclusion: These findings have important implications for obesity policy in 
Malta and other European nations with similar health systems and levels of 
population obesity, thus highlighting the need for effective population-level 
preventive strategies.
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of total health expenditure (9). Concern about childhood obesity 
continuing into adulthood and its potential to substantially 
burden the health care system has led to the publication 
of a  national strategy aimed at obesity prevention (10). The 
strategy recognizes the increasing burden of obesity in Malta 
and highlights the need for a whole-of-population approach to 
address its key determinants, with the involvement of a range of 
stakeholders across different sectors. However, the emphasis is on 
behavioural, promotional and educational measures to address 
obesity, particularly in children, rather than on measures to 
modify the overall obesogenic environment to achieve sustained 
reductions in population weight (11).
Modelling the future obesity burden is helpful to policy-makers, 
who might need to consider adopting politically controversial 
measures to meet the increase in obesity-associated health 
outcomes and costs (12). The aim of this study was to model 
the potential trajectory of unchecked obesity in Malta, estimate 
its economic and health consequences from 2015 to 2035, and 
outline the potential benefits of reducing the mean population 
BMI by 1% and 5%. Our results may help guide national resource 
allocation and emphasize the positive health and economic 
outcomes of implementing preventive measures in Malta and 
other nations with similar levels of population overweight.
METHODS
MICROSIMULATION MODEL
A two-stage modelling process developed by the United 
Kingdom’s Foresight working group and described in more 
detail elsewhere (13) was used to project the future obesity-
related disease burden in Malta. Based on the assumption 
that an individual’s BMI status does not change over time, 
cross-sectional data were used to simulate longitudinal BMI 
trajectories from 2015 to 2035. Briefly, the first module fits 
multivariate, categorical regression models to cross-sectional 
BMI data. A  BMI value is probabilistically and stochastically 
assigned to simulated individuals as a function of age, sex and 
calendar year, and the predicted proportions of the population 
in each BMI category are constrained, resulting in a longitudinal 
growth model for the population. An individual’s BMI percentile 
within the same age cohort is assumed to stay the same over 
time. Size and age distributions were based on medium variant 
projections from the United Nations population database (14). 
The availability of obesity-related disease data enabled the 
consequences of these BMI trends to be determined so that the 
risk of contracting, surviving or dying from this set of conditions 
could be simulated for each virtual individual. The subsequent 
health care costs associated with these trends could then be 
calculated. The effects of constraints on future BMI growth were 
also modelled to provide insight into how the levels of obesity-
related chronic disease prevalence, mortality and health care 
costs might change following one of three distinct scenarios:
• scenario  0: baseline scenario, i.e. obesity trends continue 
unchecked;
• scenario 1: mean population BMI decreases by 1%; and
• scenario 2: mean population BMI decreases by 5%.
A total of 20  million Monte Carlo simulation trials were 
performed for each scenario, in which reductions in mean 
population BMI were applied at the baseline year (2015). For 
reference purposes, it was estimated that reducing the average 
weight of a population by 1.25% (i.e. less than 1 kg for a person 
weighing 70 kg) would reduce the rate of obesity by 25% (15). 
Data sources for the model are shown in Table 1.
BMI DATA
Databases were included if they contained nationally 
representative BMI data. Adult data were categorized by 
WHO cut-offs for normal weight (<  25  kg/m2), pre-obesity 
(25–29.99  kg/m2) and obesity (≥  30  kg/m2), whereas child 
height and weight data were converted into BMI equivalents 
using International Obesity Task Force cut-offs (16). When 
microsimulation modelling was carried out in 2014, the only 
nationally representative BMI trend data available for Maltese 
adults were for two rounds of the European Health Interview 
Survey (EHIS), conducted in 2002 and 2008 (17, 18). Both 
measured and self-reported data for several cohorts of Maltese 
children were used as inputs for the microsimulation model. 
Additionally, the School Health Service within the Maltese 
Ministry for Health provided anthropometric data for three 
national cohorts of schoolchildren born in 2001, 2003 and 2005, 
measured at approximately 7  years of age. Anthropometric 
measurements for the 2001 cohort were repeated in 2009 
and 2010, when children had a  median age of 9 and 10  years, 
respectively. In addition, self-reported BMI data from four 
rounds of the Health Behaviour in School-aged Children survey 
conducted in Malta in 2002, 2006, 2010 and 2014 were available 
for children aged 11, 13 and 15  years (19, 20, 21, 22). Outlier 
data falling outside the 95% confidence limits were removed. 
Data were inputted into the model and BMI distribution in the 
population was estimated using regression analysis stratified by 
sex and age group. At the time of this study, these were the most 
up-to-date data available.
783
ТОМ 3  |  ВЫПУСК 4  |  ДЕКАБРЬ 2017 Г.  |  537-820ПАНОРАМА ОБЩЕСТВЕННОГО ЗДРАВООХРАНЕНИЯ
HEAlTH AND ECONOMIC CONSEquENCES OF PROJECTED OBESITy TRENDS IN MAlTA
DISEASE DATA
National epidemiological studies and routine databases were 
reviewed in 2014 to identify the incidence and prevalence 
rates of the following obesity-related diseases by age and sex: 
CHD, hypertension, obesity-related cancers (breast, colorectal, 
endometrial, kidney, liver, oesophageal and pancreas), stroke 
and type 2 diabetes. Incidence rates for CHD, diabetes and 
hypertension were derived from prevalence data obtained from 
the 2008 EHIS (18) by applying the WHO DisMod II model (29). 
The Clinical Performance Unit within Mater Dei Hospital, Malta’s 
national hospital, provided data on prevalence, incidence and 
survival rates for stroke; the Directorate for Health Information 
and Research (DHIR) provided data on the prevalence and 
incidence of obesity-related cancers (24). Mortality and survival 
data were also collected for obesity-related cancers CHD, and 
stroke (26,28). The relative comorbidity risks related to being 
overweight or obese for each of these diseases were obtained 
from the International Association for the Study of Obesity (29).
COST DATA
Direct costs of non-cancerous disease include the cost of 
inpatient stays, day patient stays, and general practitioner and 
specialist consultations. Estimated attributable costs for 2013 
were calculated by DHIR based on 2008 disease prevalence 
estimates. It was assumed that disease prevalence had not 
changed since 2008 and that any increase in cost was due to 
inflation (2% yearly) and an ageing population. Expenses related 
to medication, surgery and ancillary services were unavailable. 
Approximate direct health care costs for breast cancer and 
colorectal cancer for 2009 were obtained from a  European 
TABLE 1. DATA SOURCES FOR THE MICROSIMULATION MODEL
Category Source (year of data)
Population characteristics
BMI distribution EHIS (2002, 2008) (17,18)
School Health Services, Malta (2007–2010, 2013)a
HBSC (2002, 2006, 2010, 2014) (19, 20, 21, 22)
Population size National Statistics Office (2012) (23)
Incidence/prevalence
CHD, diabetes, hypertension EHIS (2008) (18)
Stroke DHIR & CPU (2013)b
Cancer National Cancer Registry (2013) (24)
Relative risk of obesity to disease risk International Association for the Study of Obesity (2010) (25)
Survival
CHD DHIR & CPU (2013)b
Stroke DHIR & CPU (2013)b
Cancers EUROCARE-5 study (2007) (26)
Direct costs
CHD, diabetes, hypertension, stroke DHIR (2013)c
Cancerd Luengo-Fernandez et al. (2009) (27)
Disease-specific mortality
CHD, diabetes, stroke National Mortality Register (2013) (28)
Cancer National Cancer Registry (2013) (24)
a Victoria Farrugia Sant’Angelo, Primary Child, Youth Health and Immunization Unit, Primary Health Directorate, Ministry of Health for Malta, personal communication, 
July 2015.
b Kathleen England and Alexandra Distefano, DHIR, personal communication, July 2015.
c Calculated by Dorothy Gauci.
d Breast and colorectal cancer only.
CPU: Clinical Performance Unit, Mater Dei Hospital, L-Imsida, Malta; HBSC: Health Behaviour in School-aged Children study.
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Union cost analysis study informed by a  mixture of national 
and proxy data (27); cost data on other specific obesity-related 
cancers were unavailable. Indirect costs such as those associated 
with premature mortality, productivity losses or loss of income 
due to absenteeism from work were also omitted from the study 
owing to a lack of national data on these topics at the time of the 
study.
RESULTS
BMI DISTRIBUTION
The projected prevalence of overweight and obesity (≥ 25 kg/m2) 
in the Maltese population by 2035 (scenario 0) is shown in Fig. 1: 
prevalence in men is projected to increase over this period to 79%, 
while prevalence in women (currently around 50%) is predicted to 
decrease slightly to approximately 48%. The proportion of adults 
in the overweight category is generally predicted to increase at 
the expense of the normal weight and obese categories, with the 
exception of young (25–34 years) and elderly (> 70 years) adults, 
who are predicted to have an increased obesity prevalence. The 
results also suggest an increase in the prevalence of overweight 
and obesity in children up to age 14 years by 2035 of around 17% 
and 3% in girls and boys, respectively.
DISEASE PREVALENCE AND PROJECTED 
OUTCOMES
If current obesity trends continue unabated, then the prevalence 
rates of almost all related diseases are expected to increase. The 
exception is type II diabetes: the prevalence of this disease is 
projected to continue increasing until around 2025, followed by 
a  prolonged slow decline (data not shown1). Any reduction in 
population BMI would substantially reduce disease prevalence 
and incidence. Fig. 2 shows the projected number of incident 
cases of obesity-related disease that would be prevented by 
2035 if 1% (scenario 1) and 5% (scenario 2) decreases in average 
population BMI were achieved.
Using United Nations total population projections for Malta, 
by 2025 scenario  1 is projected to decrease the number of 
CHD and stroke cases by 2037, the number of diabetes cases by 
3264 and the number of all cancer cases by 554. Scenario 2 has 
a greater impact: by 2025, the number of CHD and stroke cases 
is projected to decrease by 6025, the number of diabetes cases 
by 7674 and the number of all cancer cases by 1743. There is also 
a projected reduction in hypertension cases of 3566 and 9847 for 
scenarios 1 and 2, respectively. Fig. 2 provides an estimate of the 
reductions in cumulative incidence due to intervention by 2025 
and 2035.
ECONOMICS
Conservative estimates for 2015 suggest direct health care 
costs for diseases associated with obesity (including breast and 
1 Supplementary information is available from the corresponding author 
upon request.
FIG. 1. PROJECTED PREVALENCE RATES FOR 
OVERWEIGHT AND OBESITY IN THE MALTESE 
POPULATION BY 2035.
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FIG. 2. ESTIMATION OF CUMULATIVE INCIDENT DISEASE 
CASES AVOIDED PER 100 000 POPULATION IN SCENARIO 1 
(i.e. 1% decrease in mean population BMI) and scenario 2 (i.e. 
5% decrease in mean population BMI), relative to scenario 0 
(i.e. obesity trends continue unchecked). Ca: cancer.
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colorectal cancer, the most common obesity-related cancers, but 
excluding endometrial, kidney, liver, oesophageal and pancreatic 
cancers, for which cost data were unavailable) of around 
€32 million. In 2015, hypertension comprised 34% of this value, 
followed by diabetes (28%) and CHD and stroke combined 
(25%). The projected increase in obesity-related diseases has 
a  substantial impact on health care expenditure: assuming 
current trends remain unchanged, by 2035 the associated 
direct health care costs are conservatively projected to reach 
€43.6 million per year. By 2035, the proportion of direct health 
care costs attributable to CHD and stroke will increase to 35% 
and the proportion attributable to breast and colorectal cancers 
and arthritis will increase slightly. In contrast, the proportions 
attributable to hypertension and diabetes is expected to decrease 
by 5% and 8%, respectively. This result is consistent with 
findings in modelling studies for other European countries, 
which indicate that increases in CHD and stroke prevalence will 
be disproportionately responsible for rising expenditure (30–33). 
Table 2 shows that a 1% decrease in population BMI is estimated 
to result in an annual reduction in expenditure on obesity-
related morbidity of €2.9  million by 2025 and of €7.1  million 
by 2035. This translates to a cumulative saving of €65.5 million 
by 2035. A  5% decrease in population BMI will clearly have 
a greater impact, resulting in cumulative savings of €141 million 
by 2035 due to reductions in direct annual health care costs of 
€7.8 million and €12.2 million by 2025 and 2035, respectively.
DISCUSSION
This study modelled the impact of potential reductions in 
average population BMI on the future obesity-related disease 
burden, and is the first to report the direct health care costs of 
five key obesity-related conditions for Malta.
The results are consistent with those found elsewhere in 
Europe (34). In all countries, the projected rise in overweight 
and obesity levels is expected to lead to substantial increases 
in both the NCD burden and associated health care spending. 
Given the organization of the health system in Malta, a large 
proportion of this burden is likely to be shouldered by the 
state: public expenditure comprised almost 69% of the total 
health expenditure in 2014, with most of the remaining costs 
resulting from out-of-pocket payments and voluntary health 
insurance (8). In 2014, the total health expenditure for Malta 
was 9.75% of GDP (8), equivalent to around €678 million (at 
current market prices). Our results suggest that obesity-related 
diseases currently account for at least 4.7% of this expenditure, 
or 0.43% of GDP. This financial burden would probably be 
substantially higher if more accurate direct and indirect costs 
were included in these calculations. A recently published report 
on the cost of obesity in Malta based on EHIS BMI data also 
included some indirect costs (i.e. absenteeism, presenteeism, 
government subsidies for disability due to obesity, loss of 
earnings and loss of taxes). The total cost of adult obesity in 
2016 was estimated at around €36.3  million: €23.8  million 
in direct costs and €12.5  million in indirect costs (9). Our 
estimate of the direct cost is higher, at €33.2 million in 2016, 
probably because we used a different modelling technique that 
incorporates the relative comorbidity risks related to being 
overweight or obese.
The microsimulation model indicates that increased CHD and 
stroke incidence will have the greatest impact on the health 
care system, as the risk of developing cardiovascular diseases 
increases with age. Surprisingly, the modelled incidence 
and prevalence rates for diabetes reached a  plateau and then 
gradually declined over the next two decades, possibly due 
to the combined effects of individuals with diabetes dying 
and a  projected reduction in the birth rate (thus reducing the 
TABLE 2. DIRECT ANNUAL HEALTH CARE COSTS (IN MILLION EUROS), BY YEAR AND DISEASE
NCD Scenario 0 Scenario 1 Scenario 2
2015 2025 2035 2025a 2035a 2025a 2035a
Hypertension 11.0 12.2 13.0 11.7 (0.5) 11.6 (1.4) 10.9 (1.3) 10.4 (2.6)
Diabetes 9.0 9.2 8.8 8.1 (1.0) 6.4 (2.5) 6.8 (2.3) 5.0 (3.9)
Breast + colorectal 
cancer
4.0 5.8 6.6 5.5 (0.3) 5.9 (0.7) 5.0 (0.9) 5.5 (1.1)
CHD + stroke 8.0 12.1 15.2 11.0 (1.0) 12.7 (2.5) 10.3 (1.8) 12.8 (2.4)
Total 32.0 39.2 43.6 36.3 (2.9) 36.5 (7.1) 31.4 (7.8) 31.4 (12.2)
a Values in parentheses are estimated annual health care cost savings (in million euros), relative to scenario 0 (i.e. obesity trends continuing unchecked)
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available population who can contract the disease). Projections 
of accurate, measured anthropometric data recorded over the 
past decade showed substantial increases in childhood obesity 
rates, particularly in girls (data not shown). However, this was 
inconsistent with the projected modest increase in overweight 
and obesity rates for men, and the reduction in rates for women. 
This is most likely due to the paucity of Maltese adult BMI 
data informing the model (only two data points were available 
at the time of the study) or to the inherent inaccuracy of self-
reported BMI data used for adult projections. Cuschieri et al.'s 
nationally representative, cross-sectional study of measured 
adult BMI reported that 70% of Maltese adults are overweight 
or obese (5). Men had significantly higher rates of overweight 
(39%) and obesity (37%) compared with women (32% and 31%, 
respectively). Although measured data for men are similar to the 
self-reported EHIS data used for this model, EHIS substantially 
underestimated the true overweight and obesity prevalence rates 
for women. This discrepancy is likely to have an impact on the 
accuracy of the projections; hence, the use of measured child (4) 
and adult (5) BMI data is warranted in future simulations.
Quantification of the NCD burden is important for patients 
and public health professionals because of the long-term 
consequences for functional abilities of patients and for health 
care demand. Such data are vital for the objective appraisal of 
national policies to control NCDs. This research expands on 
the results for Malta published in a  WHO cross-European 
microsimulation study (34), which did not explore the cost of 
obesity. We set out to add value to the findings by using the 
most up-to-date data available at the time of the study and 
by deriving disease cost estimates, while avoiding the use of 
proxy data where possible. Compared with those of the WHO 
modelling study, our results show that substantially more 
cumulative incident cases are prevented across all obesity-
related diseases. While the cumulative incidence per 100 000 
population of diabetes and all cancers across the two studies 
were broadly similar, our study found that intervention would 
result in a  lower cumulative incidence for CHD and stroke, 
as well as for hypertension. There were also differences in 
estimated prevalence rates: our study found a  slightly lower 
overall projected prevalence of cancer and a substantially lower 
prevalence of CHD, diabetes and stroke compared with WHO 
calculations. Prevalence estimates for hypertension in both 
studies were broadly similar. Projections for arthritis (another 
established obesity-related disease) that used United Kingdom 
proxy data were included in the WHO estimates; however, the 
self-reported prevalence data available from the EHIS 2008 
survey were deemed insufficiently accurate to warrant the 
inclusion of this disease in the present study.
LIMITATIONS
As with all models, the quality of microsimulation modelling 
output is dependent on the accuracy of surveillance data and 
the underpinning assumptions of the model. Limitations of 
the model have been described elsewhere (13). For example, 
obesity cannot be considered to be the sole causal factor for the 
projected rise in NCDs, and it was not possible to incorporate 
the impact of economic growth or future increases in the cost of 
health care into the analysis. BMI projections for adults should 
be interpreted with caution because only two data points were 
available. Both disease prevalence and BMI data used in this 
study were self-reported and therefore likely to be biased. In 
addition, although the use of cross-sectional data to construct 
BMI trajectories may not be applicable to upcoming generations, 
the model assumed that any BMI changes occurring as a result 
of interventions would be fixed over time. Furthermore, high-
quality health care data was difficult to locate, thus limiting the 
accuracy of our findings. Although bariatric surgery is still in its 
infancy in Malta (and hence unlikely to contribute significantly 
to overall costs), the lack of data related to ancillary services 
and medications prescribed for obesity-related disease is a key 
limitation of this study. Direct costs for endometrial, kidney, 
liver, oesophageal and pancreatic cancers were not included due 
to lack of accessible data; hence, study estimates are likely to be 
gross underestimations of the true cost. On the other hand, it 
is difficult to disentangle the potentially overlapping costs of 
related diseases such as CVD, diabetes, hypertension and stroke; 
hence, there may be some error in our cost estimates. Finally, no 
indirect cost data for Malta was available at the time of modelling; 
hence, these costs could not be included. Given these limitations, 
our results should be interpreted with caution as the actual cost 
of obesity-related disease is likely to be much higher than that 
outlined in our study. A similar analysis by a private company 
used measured BMI data from Cuschieri and colleague’s 
study (5) (which was not available when this microsimulation 
modelling was conducted) and supplemented the direct health 
care cost estimates calculated by DHIR (which were used in this 
modelling study) with estimated indirect costs (9). The analysis 
indicated that self-reported BMI data underestimates the total 
cost of obesity by around €20 million per year, with most of this 
additional expense due to indirect costs.
There remains a need to establish more accurate estimates for 
the prevalence of obesity-related disease in Malta, as well as 
the associated direct and indirect costs. Since this study was 
conducted, additional data which may help to address the 
study limitations have become available. The recently published 
measured BMI data for children (4) and adults (5) and indirect 
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costs of obesity (9) should be used for future microsimulation 
modelling of obesity in Malta.
CONCLUSION
Although the Maltese Government has developed a  national 
strategic plan to improve the diet and physical activity patterns of 
the population, translating policy into tangible action is unlikely 
to be a straightforward process. Public health professionals may 
find it difficult to persuade budget-conscious policy-makers to 
consider preventive interventions that are likely to bear fruit 
years  – rather than months  – into the future. This research 
provides evidence of preventable direct health care costs for five 
major obesity-related illnesses using a  recognized forecasting 
model, and thereby an impetus for policy-makers to adopt long-
term objectives. Any reduction in population overweight and 
obesity levels will result in substantial cost savings for decades. 
Although the Maltese national obesity strategy focuses on 
behavioural and educational measures to address the obesity 
burden, multicomponent, population-level interventions 
addressing drivers of obesity at multiple levels (e.g. fiscal 
measures) are the most likely to be effective (35, 36). Collecting 
disaggregated surveillance data related to disease costs and 
the indirect costs of obesity and using this along with recently 
published measured BMI data would enhance the accuracy of 
future modelling efforts.
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